VSee Health｜10-Q：2025 財年 Q2 營收 3.39 百萬美元

Revenue: As of FY2025 Q2, the actual value is USD 3.39 M.

EPS: As of FY2025 Q2, the actual value is USD -0.16.

EBIT: As of FY2025 Q2, the actual value is USD -2.014 M.

Segment Revenue

• Technology Segment: Revenue for the six months ended June 30, 2025, was $4,458,800, compared to $3,269,992 for the same period in 2024, representing an increase of $1,188,808 or 36%.
• Telehealth Segment: Revenue for the six months ended June 30, 2025, was $2,252,805, compared to $62,569 for the same period in 2024, representing an increase of $2,190,236 or 3,501%.

Operational Metrics

• Gross Margin: For the six months ended June 30, 2025, the Technology segment reported a gross margin of $2,023,181, while the Telehealth segment reported a gross margin of $1,425,282.
• Operating Income (Loss): The Technology segment reported an operating loss of - $83,969 for the six months ended June 30, 2025, while the Telehealth segment reported an operating loss of - $1,300,001.

Cash Flow

• Net Cash Used in Operating Activities: For the six months ended June 30, 2025, net cash used in operating activities was - $765,094, compared to - $2,594,214 for the same period in 2024.
• Net Cash Used in Investing Activities: For the six months ended June 30, 2025, net cash used in investing activities was - $15,466, compared to - $16,390 for the same period in 2024.
• Net Cash Provided by Financing Activities: For the six months ended June 30, 2025, net cash provided by financing activities was $746,040, compared to $3,597,841 for the same period in 2024.

Unique Metrics

• Amortization Expense: For the six months ended June 30, 2025, the Company recorded amortization expense of $1,149,998 within general and administrative expenses.

Future Outlook and Strategy

• Core Business Focus: The Company plans to leverage its industry relationships with government, hospital systems, and insurance providers to increase its customer base and expand within the telehealth market.
• Non-Core Business: The Company is exploring additional financing options to support its working capital needs and fund growth initiatives.

Priority

• The Company emphasizes strategies with concrete projections, such as expanding its telehealth offerings and leveraging its scalable technology platform to meet the unique needs of the healthcare industry.